Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Essential role of signal transducer and activator of transcription (Stat)5a but not Stat5b for Flt3-dependent signaling.

Zhang S, Fukuda S, Lee Y, Hangoc G, Cooper S, Spolski R, Leonard WJ, Broxmeyer HE.

J Exp Med. 2000 Sep 4;192(5):719-28.

2.

Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.

Drexler HG.

Leukemia. 1996 Apr;10(4):588-99. Review.

PMID:
8618433
3.

JAK/STAT-dependent gene regulation by cytokines.

Hebenstreit D, Horejs-Hoeck J, Duschl A.

Drug News Perspect. 2005 May;18(4):243-9. Review.

PMID:
16034480
4.

Janus kinases (JAKs) and signal transducers and activators of transcription (STATs) in hematopoietic cells.

Nosaka T, Kitamura T.

Int J Hematol. 2000 Jun;71(4):309-19. Review. Erratum in: Int J Hematol 2000 Jul;72(1):124.

PMID:
10905049
5.

The Jak-STAT pathway.

Imada K, Leonard WJ.

Mol Immunol. 2000 Jan-Feb;37(1-2):1-11. Review.

PMID:
10781830
6.

Signal transducer and activator of transcription proteins in leukemias.

Benekli M, Baer MR, Baumann H, Wetzler M.

Blood. 2003 Apr 15;101(8):2940-54. Epub 2002 Dec 12. Review.

7.

Jaks and Stats in cytokine signaling.

Ihle JN, Nosaka T, Thierfelder W, Quelle FW, Shimoda K.

Stem Cells. 1997;15 Suppl 1:105-11; discussion 112. Review.

8.

Biology of flt3 ligand and receptor.

Lyman SD.

Int J Hematol. 1995 Aug;62(2):63-73. Review.

PMID:
8590775
9.

Jaks, STATs, Cytokines, and Sepsis.

Scott MJ, Godshall CJ, Cheadle WG.

Clin Diagn Lab Immunol. 2002 Nov;9(6):1153-9. Review. No abstract available.

10.
11.

STAT5-Interacting Proteins: A Synopsis of Proteins that Regulate STAT5 Activity.

Able AA, Burrell JA, Stephens JM.

Biology (Basel). 2017 Mar 11;6(1). pii: E20. doi: 10.3390/biology6010020. Review.

12.

STAT5 acetylation: Mechanisms and consequences for immunological control and leukemogenesis.

Kosan C, Ginter T, Heinzel T, Krämer OH.

JAKSTAT. 2013 Oct 1;2(4):e26102. doi: 10.4161/jkst.26102. Epub 2013 Aug 19. Review.

13.

STAT inhibitors for cancer therapy.

Furqan M, Akinleye A, Mukhi N, Mittal V, Chen Y, Liu D.

J Hematol Oncol. 2013 Dec 5;6:90. doi: 10.1186/1756-8722-6-90. Review.

Supplemental Content

Support Center